|
Symbol Name ID |
Spink5
serine peptidase inhibitor, Kazal type 5 MGI:1919682 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| F2rl1tm1Cgh/F2rl1tm1Cgh Spink5tm1Hov/Spink5tm1Hov involves: 129P2/OlaHsd * 129S4/SvJae |
abnormal epidermis stratum corneum morphology | J:180855 |
| abnormal skin morphology | J:180855 | |
| abnormal vibrissa morphology | J:180855 | |
| acanthosis | J:180855 | |
| dehydration | J:180855 | |
| neonatal lethality, complete penetrance | J:180855 | |
| Klk6tm1Gsot/Klk6tm1Gsot Spink5tm1Drh/Spink5tm1Drh involves: 129P2/OlaHsd * C57BL/6 |
abnormal cytokine level | J:289877 |
| abnormal epidermis stratum corneum morphology | J:289877 | |
| abnormal skin morphology | J:289877 | |
| abnormal vibrissa morphology | J:289877 | |
| decreased inflammatory response | J:289877 | |
| epidermal desquamation | J:289877 | |
| impaired skin barrier function | J:289877 | |
| normal integument phenotype | J:289877 | |
| neonatal lethality, complete penetrance | J:289877 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/06/2026 MGI 6.24 |
|
|
|
||